Andrew S. Fein Recent News
H.C. Wainwright Still Buying Amarin, Sees DMC Decision By Summer
H.C. Wainwright: Time To Buy Insmed
Vertex Shares Rally As FDA Panel Backs Orkambi; HC Wainwright Analyst Offers Thoughts
Analyst Calls OvaScience Data 'Promising' But Early
Why OvaScience Shares Soared 35%
H.C. Wainwright Highlights Its Top Picks Ahead Of NACFC 2014
UPDATE: H.C. Wainwright & Co. Initiates Coverage on Seattle Genetics on Good Potential for Adcetris
UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst Pharmaceuticals on Positive Expectations for Oral HAE Drug